{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T04:27:21Z","timestamp":1781497641531,"version":"3.54.1"},"reference-count":111,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.seizure.2021.06.004","type":"journal-article","created":{"date-parts":[[2021,6,6]],"date-time":"2021-06-06T19:47:07Z","timestamp":1623008827000},"page":"117-131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Antiepileptic drugs and serotonin syndrome- A systematic review of case series and case reports"],"prefix":"10.1016","volume":"91","author":[{"given":"Sanjay","family":"Prakash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaturbhuj","family":"Rathore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaushik","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harsh","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2021.06.004_bib0001","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1056\/NEJMra041867","article-title":"The serotonin syndrome","volume":"352","author":"Boyer","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.seizure.2021.06.004_bib0002","doi-asserted-by":"crossref","first-page":"g1626","DOI":"10.1136\/bmj.g1626","article-title":"Serotonin syndrome","volume":"348","author":"Buckley","year":"2014","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.seizure.2021.06.004_bib0003","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/15563650.2020.1839662","article-title":"Fatal serotonin syndrome: a systematic review of 56 cases in the literature","volume":"59","author":"Prakash","year":"2021","journal-title":"Clinical Toxicology Clin Toxicol (Phila)"},{"key":"10.1016\/j.seizure.2021.06.004_bib0004","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1528-1167.2010.02908.x","article-title":"The serotonin axis: shared mechanisms in seizures, depression, and SUDEP","volume":"52","author":"Richerson","year":"2011","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.seizure.2021.06.004_bib0005","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1471-4159.2006.04277.x","article-title":"Serotonin and epilepsy","volume":"100","author":"Bagdy","year":"2007","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/j.seizure.2021.06.004_bib0006","doi-asserted-by":"crossref","first-page":"8","DOI":"10.9740\/mhc.2015.01.008","article-title":"Pharmacokinetic characteristics of antiepileptic drugs (AEDs)","volume":"6","author":"Marvanova","year":"2016","journal-title":"Mental Health Clinician."},{"issue":"2","key":"10.1016\/j.seizure.2021.06.004_bib0007","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1212\/WNL.45.2.219","article-title":"Serotonin syndrome","volume":"45","author":"Bodner","year":"1995","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.seizure.2021.06.004_bib0008","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1176\/ajp.148.6.705","article-title":"The serotonin syndrome","volume":"148","author":"Sternbach","year":"1991","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.seizure.2021.06.004_bib0009","doi-asserted-by":"crossref","DOI":"10.1093\/qjmed\/hcg109","article-title":"The hunter serotonin toxicity criteria: simple and accurate diagnostic decision rules for serotonin toxicity","volume":"96","author":"Dunkley","year":"2003","journal-title":"QJM"},{"issue":"2","key":"10.1016\/j.seizure.2021.06.004_bib0010","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0196-0644(97)70283-X","article-title":"Serotonin syndrome associated with nefazodone and paroxetine","volume":"29","author":"John","year":"1997","journal-title":"Ann Emerg Med"},{"issue":"4","key":"10.1016\/j.seizure.2021.06.004_bib0011","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0196-0644(97)70022-2","article-title":"Toxic effects of nefazodone","volume":"30","author":"Brazelton","year":"1997","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.seizure.2021.06.004_bib0012","article-title":"Antidepressants and the serotonin syndrome in general practice","volume":"49","author":"Mackay","year":"1999","journal-title":"Br J Gen Pract"},{"issue":"4","key":"10.1016\/j.seizure.2021.06.004_bib0013","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/00005792-200007000-00001","article-title":"Serotonin syndrome. Presentation of 2 cases and review of the literature","volume":"79","author":"Mason","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.seizure.2021.06.004_bib0014","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1345\/aph.10203","article-title":"Serotonin syndrome: early management with cyproheptadine","volume":"35","author":"McDaniel","year":"2001","journal-title":"Ann Pharmacother"},{"issue":"10","key":"10.1016\/j.seizure.2021.06.004_bib0015","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/00002030-200107060-00010","article-title":"Serotonin syndrome in HIV-infected individuals receiving antiretroviral therapy and fluoxetine","volume":"15","author":"DeSilva","year":"2001","journal-title":"Aids"},{"issue":"6","key":"10.1016\/j.seizure.2021.06.004_bib0016","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2515\/therapie:2006075","article-title":"Manic Switch and Serotonin Syndrome with Venlafaxine-Lithium-Valproate Association","volume":"61","author":"Liberek","year":"2006","journal-title":"Therapies"},{"issue":"19","key":"10.1016\/j.seizure.2021.06.004_bib0017","doi-asserted-by":"crossref","first-page":"S252","DOI":"10.1016\/S0924-977X(09)70363-3","article-title":"Opiates and SSRI's: risk for serotonin syndrome (P. 1. c. 003)","author":"Timmerman","year":"2009","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.seizure.2021.06.004_bib0018","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-204154","article-title":"Serotonin syndrome versus neuroleptic malignant syndrome: a challenging clinical quandary","volume":"2014","author":"Dosi","year":"2014","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.seizure.2021.06.004_bib0019","doi-asserted-by":"crossref","first-page":"226","DOI":"10.4103\/0972-2327.150612","article-title":"Mild serotonin syndrome: a report of 12 cases","volume":"18","author":"Prakash","year":"2015","journal-title":"Ann Indian Acad Neurol"},{"issue":"9","key":"10.1016\/j.seizure.2021.06.004_bib0020","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/s10072-016-2638-2","article-title":"Serotonin syndrome presenting as febrile encephalopathy with CSF pleocytosis: a report of three cases","volume":"37","author":"Prakash","year":"2016","journal-title":"Neurol Sci"},{"key":"10.1016\/j.seizure.2021.06.004_bib0021","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-221383","article-title":"Serotonin syndrome in patients with headache disorders","author":"Prakash","year":"2017","journal-title":"BMJ Case Rep"},{"issue":"3","key":"10.1016\/j.seizure.2021.06.004_bib0022","doi-asserted-by":"crossref","first-page":"371","DOI":"10.24869\/psyd.2019.371","article-title":"GHB Roller-Coaster: serotonin Syndrome and Withdrawal","volume":"31","author":"Kuharic","year":"2019","journal-title":"Psychiatr Danub"},{"issue":"1","key":"10.1016\/j.seizure.2021.06.004_bib0023","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4103\/0028-3886.253624","article-title":"Neuromuscular abnormalities in serotonin syndrome may be mistaken as seizure: a report and literature review","volume":"67","author":"Prakash","year":"2019","journal-title":"Neurol India"},{"key":"10.1016\/j.seizure.2021.06.004_bib0024","doi-asserted-by":"crossref","first-page":"52","DOI":"10.4103\/aian.AIAN_344_18","article-title":"Refining the clinical features of serotonin syndrome: a prospective observational study of 45 patients","volume":"22","author":"Prakash","year":"2019","journal-title":"Ann Indian Acad Neurol"},{"issue":"5","key":"10.1016\/j.seizure.2021.06.004_bib0025","doi-asserted-by":"crossref","first-page":"331","DOI":"10.9740\/mhc.2019.09.331","article-title":"Successful use of carbamazepine in a patient with drug rash with eosinophilia and systemic symptoms","volume":"9","author":"Bixby","year":"2019","journal-title":"Mental Health Clinician"},{"key":"10.1016\/j.seizure.2021.06.004_bib0026","article-title":"Clinical Relevance of Pharmacogenetics in Serotonin Syndrome","volume":"2020","author":"Pandya","year":"2020","journal-title":"Case Rep Psychiatry"},{"key":"10.1016\/j.seizure.2021.06.004_bib0027","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jcrc.2020.12.014","article-title":"The prevalence of serotonin syndrome in an intensive care unit: a prospective observational study","volume":"63","author":"Prakash","year":"2021","journal-title":"J Crit Care"},{"issue":"12","key":"10.1016\/j.seizure.2021.06.004_bib0028","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1177\/0960327106073832","article-title":"Olanzapine overdose is associated with acute muscle toxicity","volume":"25","author":"Waring","year":"2006","journal-title":"Hum Exp Toxicol"},{"issue":"2","key":"10.1016\/j.seizure.2021.06.004_bib0029","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1177\/875512250602200208","article-title":"Combination of methylphenidate, venlafaxine, and escitalopram resulting in serotonin syndrome","volume":"22","author":"Lizer","year":"2006","journal-title":"J Pharm Technol"},{"issue":"5","key":"10.1016\/j.seizure.2021.06.004_bib0030","first-page":"367","article-title":"Serotonin syndrome following lamotrigine overdose","volume":"46","author":"Wood","year":"2008","journal-title":"Clin Toxicol"},{"issue":"2","key":"10.1016\/j.seizure.2021.06.004_bib0031","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1213\/ANE.0b013e3181c76be9","article-title":"Serotonin syndrome in the perioperative period","volume":"110","author":"Altman","year":"2010","journal-title":"Anesth Analg"},{"issue":"1","key":"10.1016\/j.seizure.2021.06.004_bib0032","first-page":"93","article-title":"Lipid therapy for serotonin syndrome after intoxication with venlafaxine, lamotrigine and diazepam","volume":"77","author":"Dagtekin","year":"2010","journal-title":"Minerva anestesiol"},{"issue":"3","key":"10.1016\/j.seizure.2021.06.004_bib0033","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s13181-013-0309-8","article-title":"Case files of the University of California San Francisco Medical Toxicology Fellowship: acute chlorine gas inhalation and the utility of nebulized sodium bicarbonate","volume":"9","author":"Vajner","year":"2013","journal-title":"J Med Toxicol"},{"issue":"7","key":"10.1016\/j.seizure.2021.06.004_bib0034","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3109\/15563650.2013.818685","article-title":"A case series of patients with lamotrigine toxicity at one center from 2003 to 2012","volume":"51","author":"Moore","year":"2013","journal-title":"Clin Toxicol"},{"issue":"2","key":"10.1016\/j.seizure.2021.06.004_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajem.2012.05.039","article-title":"Monomorphic ventricular tachycardia after intentional citalopram overdose","volume":"31","author":"Maddry","year":"2013","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.seizure.2021.06.004_bib0036","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1213\/XAA.0000000000000010","article-title":"Serotonin syndrome after cardiopulmonary bypass: a case demonstrating the interaction between methylene blue and selective serotonin reuptake inhibitors","volume":"2","author":"Hanna","year":"2014","journal-title":"A&A Case Reports"},{"key":"10.1016\/j.seizure.2021.06.004_bib0037","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/769531","article-title":"Serotonin Syndrome in the Setting of Lamotrigine, Aripiprazole, and Cocaine Use","volume":"2015","author":"Kotwal","year":"2015","journal-title":"Case Rep Med"},{"issue":"6","key":"10.1016\/j.seizure.2021.06.004_bib0038","first-page":"1199","article-title":"Cervical Spinal Cord Stimulation with Concomitant Serotonin Norepinephrine Reuptake Inhibitor Therapy Leading to the Serotonin Syndrome","volume":"18","author":"Dizdarevic","year":"2017","journal-title":"Pain Med"},{"issue":"6","key":"10.1016\/j.seizure.2021.06.004_bib0039","doi-asserted-by":"crossref","first-page":"737","DOI":"10.2169\/internalmedicine.56.7727","article-title":"Metoclopramide-induced serotonin syndrome","volume":"56","author":"Harada","year":"2017","journal-title":"Intern Med"},{"issue":"5","key":"10.1016\/j.seizure.2021.06.004_bib0040","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/jcpt.12698","article-title":"Bicarbonate refractory QRS prolongation and left bundle-branch block following escitalopram and lamotrigine overdose: a case report and literature review of toxic left bundle-branch block","volume":"43","author":"Farkas","year":"2018","journal-title":"J Clin Pharm Ther"},{"issue":"11","key":"10.1016\/j.seizure.2021.06.004_bib0041","first-page":"e3616","article-title":"Desmarais EC. Serotonin Syndrome with Atypical Hypernatremia","volume":"10","author":"Rubin","year":"2018","journal-title":"Cureus."},{"issue":"4","key":"10.1016\/j.seizure.2021.06.004_bib0042","doi-asserted-by":"crossref","first-page":"A1959","DOI":"10.1016\/j.chest.2019.08.1943","article-title":"Lamotrigine overdose requiring intubation and active cooling","volume":"156","author":"Oroian","year":"2019","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.seizure.2021.06.004_bib0043","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/01.ccm.0000633104.90558.66","article-title":"892: antiepileptic failure or side effect? The misdiagnosis of serotonin syndrome as status epilepticus","volume":"48","author":"Phillips","year":"2020","journal-title":"Critical Care Medicine"},{"issue":"6","key":"10.1016\/j.seizure.2021.06.004_bib0044","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.nrleng.2018.03.017","article-title":"Encephalopathy secondary to lamotrigine toxicity","volume":"35","author":"Gil","year":"2020","journal-title":"Neurologia (English Edition)"},{"issue":"3","key":"10.1016\/j.seizure.2021.06.004_bib0045","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4103\/jrpp.JRPP_19_105","article-title":"Serotonin Toxicity Following Suicide with Citalopram and Lamotrigine: a Rare Case Report and Literature Review","volume":"9","author":"Dorooshi","year":"2020","journal-title":"J Res Pharm Pract"},{"key":"10.1016\/j.seizure.2021.06.004_bib0046","article-title":"Slow on the Uptake, Progression to Heartbreak","volume":"8","author":"Binder","year":"2020","journal-title":"J Investig Med High Impact Case Rep"},{"issue":"1","key":"10.1016\/j.seizure.2021.06.004_bib0047","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/JCP.0000000000001159","article-title":"Use of Cyproheptadine for the Treatment of Serotonin Syndrome: a Case Series","volume":"40","author":"Frye","year":"2020","journal-title":"J Clin Psychopharmacol"},{"issue":"10","key":"10.1016\/j.seizure.2021.06.004_bib0048","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1345\/aph.1C091","article-title":"Serotonin syndrome induced by amitriptyline, meperidine, and venlafaxine","volume":"36","author":"Dougherty","year":"2002","journal-title":"Ann Pharmacother"},{"issue":"5","key":"10.1016\/j.seizure.2021.06.004_bib0049","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1345\/aph.1E523","article-title":"Serotonin toxicity associated with concomitant use of linezolid","volume":"39","author":"Bergeron","year":"2005","journal-title":"Ann Pharmacother"},{"issue":"3","key":"10.1016\/j.seizure.2021.06.004_bib0050","doi-asserted-by":"crossref","first-page":"71","DOI":"10.18773\/austprescr.2006.044","article-title":"Serotonin syndrome precipitated by an over-the-counter cold remedy","volume":"29","author":"Cameron","year":"2006","journal-title":"Aust Prescr"},{"issue":"6","key":"10.1016\/j.seizure.2021.06.004_bib0051","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/01.jcp.0000239793.29449.75","article-title":"Serotonin syndrome precipitated by linezolid in a medically ill patient on duloxetine","volume":"26","author":"Strouse","year":"2006","journal-title":"J Clin Psychopharmacol"},{"issue":"7","key":"10.1016\/j.seizure.2021.06.004_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajem.2008.01.039","article-title":"Serotonin syndrome triggered by a single dose of suboxone","volume":"26","author":"Isenberg","year":"2008","journal-title":"Am J Emerg Med"},{"issue":"8","key":"10.1016\/j.seizure.2021.06.004_bib0053","doi-asserted-by":"crossref","DOI":"10.1111\/j.1526-4637.2012.01468.x","article-title":"Serotonin Syndrome in a Patient with Chronic Pain Polypharmacy","volume":"15","author":"Lamberg","year":"2014","journal-title":"Pain Med."},{"key":"10.1016\/j.seizure.2021.06.004_bib0054","first-page":"562","article-title":"Transient serotonin syndrome caused by concurrent use of tramadol and selective serotonin reuptake inhibitor","author":"Shakoor","year":"2014","journal-title":"Am J Case Rep"},{"issue":"10","key":"10.1016\/j.seizure.2021.06.004_bib0055","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/pu.30083","article-title":"Serotonin syndrome associated with morphine-phenelzine interaction","volume":"26","author":"Lam","year":"2015","journal-title":"The Brown University Psychopharmacology Update"},{"issue":"4","key":"10.1016\/j.seizure.2021.06.004_bib0056","doi-asserted-by":"crossref","first-page":"254","DOI":"10.4103\/0019-5049.155008","article-title":"Cardiac arrest from tramadol and fentanyl combination","volume":"59","author":"Nair","year":"2015","journal-title":"Indian J Anaesth"},{"issue":"6","key":"10.1016\/j.seizure.2021.06.004_bib0057","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1002\/phar.1581","article-title":"Serotonin syndrome probably triggered by a morphine-phenelzine interaction","volume":"35","author":"Mateo-Carrasco","year":"2015","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.seizure.2021.06.004_bib0058","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.wneu.2019.03.092","article-title":"Serotonin Syndrome Following Tramadol and Gabapentin Use After Spine Surgery","volume":"126","author":"Ek\u015fi","year":"2019","journal-title":"World Neurosurg"},{"issue":"4","key":"10.1016\/j.seizure.2021.06.004_bib0059","doi-asserted-by":"crossref","first-page":"A2196","DOI":"10.1016\/j.chest.2019.08.2126","article-title":"Suboxone-induced serotonin syndrome","volume":"156","author":"Giblin","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.seizure.2021.06.004_bib0060","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/0140-6736(93)92860-V","article-title":"Toxic serotonin syndrome after fluoxetine plus carbamazepine","volume":"342","author":"Durson","year":"1993","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.seizure.2021.06.004_bib0061","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/NRL.0b013e31825cf3f3","article-title":"Fatal serotonin syndrome precipitated by oxcarbazepine in a patient using an selective serotonin reuptake inhibitor","volume":"18","author":"Dardis","year":"2012","journal-title":"Neurologist"},{"issue":"4","key":"10.1016\/j.seizure.2021.06.004_bib0062","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.yebeh.2009.01.018","article-title":"Antidepressant-associated myoclonic status in a patient with symptomatic generalized epilepsy: does risk occur with therapeutic doses?","volume":"14","author":"Melani","year":"2009","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2021.06.004_bib0063","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1016\/S1090-3798(09)70349-6","article-title":"P291 Case report of serotonin syndrome in a 14 year old girl","volume":"13","author":"Bagshaw","year":"2009","journal-title":"Eur J Paediatr Neurol"},{"issue":"3","key":"10.1016\/j.seizure.2021.06.004_bib0064","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s10072-011-0546-z","article-title":"Serotonin toxicity: a short review of the literature and two case reports involving citalopram","volume":"32","author":"Talarico","year":"2011","journal-title":"Neurol Sci"},{"issue":"10S","key":"10.1016\/j.seizure.2021.06.004_bib0065","article-title":"Fatal outcome of status epilepticus, hyperthermia, rhabdomyolysis, multi-organ failure, and cerebral edema after 25I-NBOMe ingestion","volume":"82","author":"Umemura","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2021.06.004_bib0066","first-page":"100","article-title":"Serotonin syndrome: a case report from India","volume":"10","author":"Jain","year":"2007","journal-title":"Ger J Psychiatry"},{"issue":"6","key":"10.1016\/j.seizure.2021.06.004_bib0067","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1213\/01.ane.0000247699.81580.eb","article-title":"Serotonin syndrome from the interaction of cyclobenzaprine with other serotoninergic drugs","volume":"103","author":"Keegan","year":"2006","journal-title":"Anesth Analg"},{"issue":"2","key":"10.1016\/j.seizure.2021.06.004_bib0068","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1055\/s-0030-1268420","article-title":"Serotonin syndrome after discontinuation of olanzapine in a combined treatment with duloxetine \u2013 case report","volume":"44","author":"Himmighoffen","year":"2011","journal-title":"Pharmacopsychiatry"},{"issue":"5","key":"10.1016\/j.seizure.2021.06.004_bib0069","doi-asserted-by":"crossref","first-page":"E632","DOI":"10.36076\/ppj.2013\/16\/E632","article-title":"Serotonin syndrome with perioperative oxycodone and pregabalin","volume":"16","author":"Song","year":"2013","journal-title":"Pain Physician"},{"issue":"4","key":"10.1016\/j.seizure.2021.06.004_bib0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.genhosppsych.2014.03.012","article-title":"Serotonin syndrome in patients with peripheral neuropathy: a diagnostic challenge","volume":"36","author":"Prakash","year":"2014","journal-title":"Gen Hosp Psychiatry"},{"issue":"3","key":"10.1016\/j.seizure.2021.06.004_bib0071","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1177\/1751143715626732","article-title":"The role of electroencephalography in the diagnosis of serotonin syndrome","volume":"17","author":"Krishnamoorthy","year":"2016","journal-title":"J Intensive Care Soc"},{"issue":"5","key":"10.1016\/j.seizure.2021.06.004_bib0072","doi-asserted-by":"crossref","first-page":"1","DOI":"10.9734\/IJMPCR\/2016\/28356","article-title":"Serotonin syndrome after initiation of pregabalin on a stable regimen of antidepressant medication","volume":"7","author":"Jellestad","year":"2016","journal-title":"Int J Med Pharm Case Reports"},{"issue":"2","key":"10.1016\/j.seizure.2021.06.004_bib0073","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-239152","article-title":"Fever in a patient with osteomyelitis: the diagnosis could be serotonin syndrome","volume":"14","author":"Gould","year":"2021","journal-title":"BMJ Case Rep"},{"issue":"1","key":"10.1016\/j.seizure.2021.06.004_bib0074","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s10194-016-0711-0","article-title":"Genetic and biochemical changes of the serotonergic system in migraine pathobiology","volume":"18","author":"Gasparini","year":"2017","journal-title":"J Headache Pain"},{"issue":"3","key":"10.1016\/j.seizure.2021.06.004_bib0075","doi-asserted-by":"crossref","first-page":"196","DOI":"10.9758\/cpn.2014.12.3.196","article-title":"Serotonin and mental disorders: a concise review on molecular neuroimaging evidence","volume":"12","author":"Lin","year":"2014","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"10.1016\/j.seizure.2021.06.004_bib0076","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3389\/fphar.2015.00046","article-title":"Central serotonin-2A (5-HT2A) receptor dysfunction in depression and epilepsy: the missing link?","volume":"6","author":"Guiard","year":"2015","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.seizure.2021.06.004_bib0077","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.2042-7158.1985.tb05040.x","article-title":"Effect of valproic acid on 5-hydroxytryptamine turnover in mouse brain","volume":"37","author":"Whitton","year":"1985","journal-title":"J Pharm Pharmacol"},{"issue":"1","key":"10.1016\/j.seizure.2021.06.004_bib0078","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0197-0186(94)90130-9","article-title":"Sodium valproate induced alterations in monoamine levels in different regions of the rat brain","volume":"24","author":"Baf","year":"1994","journal-title":"Neurochem Int"},{"issue":"5","key":"10.1016\/j.seizure.2021.06.004_bib0079","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/j.1471-4159.2004.02690.x","article-title":"Effect of valproic acid on serotonin-2A receptor signaling in C6 glioma cells","volume":"90","author":"Sullivan","year":"2004","journal-title":"J Neurochem"},{"issue":"5","key":"10.1016\/j.seizure.2021.06.004_bib0080","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0893-133X(97)00167-X","article-title":"Divalproex sodium attenuates growth hormone response to baclofen in healthy human males","volume":"18","author":"Shiah","year":"1998","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.seizure.2021.06.004_bib0081","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0165-1781(97)00046-2","article-title":"Effects of subchronic treatment with valproate on l-5-HTP-induced cortisol responses in mania: evidence for increased central serotonergic neurotransmission","volume":"71","author":"Maes","year":"1997","journal-title":"Psychiatry Res"},{"issue":"1","key":"10.1016\/j.seizure.2021.06.004_bib0082","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.seizure.2021.06.004_bib0083","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1055\/s-0028-1102912","article-title":"French Association of Regional Pharmacovigilance Centres. Confusion, a rather serious adverse drug reaction with valproic acid: a review of the French Pharmacovigilance database","volume":"42","author":"Bondon-Guitton","year":"2009","journal-title":"Pharmacopsychiatry"},{"issue":"6","key":"10.1016\/j.seizure.2021.06.004_bib0084","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s40263-016-0341-8","article-title":"Valproate-associated parkinsonism: a critical review of the literature","volume":"30","author":"Brugger","year":"2016","journal-title":"CNS Drugs"},{"issue":"6","key":"10.1016\/j.seizure.2021.06.004_bib0085","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1097\/JCP.0000000000001121","article-title":"Serotonin Toxicity: associated Agents and Clinical Characteristics","volume":"39","author":"Moss","year":"2019","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"10.1016\/j.seizure.2021.06.004_bib0086","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/jcpt.12796","article-title":"An 11-year retrospective review of cyproheptadine use in serotonin syndrome cases reported to the California Poison Control System","volume":"44","author":"Nguyen","year":"2019","journal-title":"J Clin Pharm Ther"},{"issue":"11","key":"10.1016\/j.seizure.2021.06.004_bib0087","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1345\/aph.1E192","article-title":"Evaluation of lamotrigine toxicity reported to poison centers","volume":"38","author":"Lofton","year":"2004","journal-title":"Ann Pharmacother"},{"issue":"1","key":"10.1016\/j.seizure.2021.06.004_bib0088","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/sj.bjp.0705737","article-title":"Effect of acute and chronic lamotrigine on basal and stimulated extracellular 5-hydroxytryptamine and dopamine in the hippocampus of the freely moving rat","volume":"142","author":"Ahmad","year":"2004","journal-title":"Br J Pharmacol"},{"issue":"6","key":"10.1016\/j.seizure.2021.06.004_bib0089","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.euroneuro.2006.01.003","article-title":"Dual monoamine modulation for the antidepressant-like effect of lamotrigine in the modified forced swimming test","volume":"16","author":"Consoni","year":"2006","journal-title":"Eur Neuropsychopharmacol"},{"issue":"4","key":"10.1016\/j.seizure.2021.06.004_bib0090","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00213-008-1074-2","article-title":"The effect of lamotrigine on platelet serotonin concentration in patients with bipolar depression","volume":"197","author":"Sagud","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"10.1016\/j.seizure.2021.06.004_bib0091","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0014-2999(98)00580-9","article-title":"Lamotrigine inhibits monoamine uptake in vitro and modulates 5-hydroxytryptamine uptake in rats","volume":"358","author":"Southam","year":"1998","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.seizure.2021.06.004_bib0092","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4196\/kjpp.2017.21.2.169","article-title":"Lamotrigine, an antiepileptic drug, inhibits 5-HT3 receptor currents in NCB-20 neuroblastoma cells","volume":"21","author":"Kim","year":"2017","journal-title":"Korean J Physiol Pharmacol"},{"issue":"4","key":"10.1016\/j.seizure.2021.06.004_bib0093","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1528-1167.2010.02966.x","article-title":"The adverse event profile of pregabalin: a systematic review and meta-analysis of randomized controlled trials","volume":"52","author":"Zaccara","year":"2011","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.seizure.2021.06.004_bib0094","doi-asserted-by":"crossref","first-page":"96","DOI":"10.4103\/bc.bc_57_19","article-title":"Pregabalin-associated movement disorders: a literature review","volume":"6","author":"Rissardo","year":"2020","journal-title":"Brain Circ"},{"issue":"2","key":"10.1016\/j.seizure.2021.06.004_bib0095","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF01243384","article-title":"Gabapentin augments whole blood serotonin in healthy young men","volume":"73","author":"Rao","year":"1988","journal-title":"J Neural Transm"},{"issue":"11","key":"10.1016\/j.seizure.2021.06.004_bib0096","first-page":"1702","article-title":"Antidepressant like Effect of Gabapentin Decreases the Immobility Time in Despair Animal Models in Mice: roll of Serotonergic System in it","volume":"4","author":"Venkatesh","year":"2011","journal-title":"Research Journal of Pharmacy and Technology"},{"key":"10.1016\/j.seizure.2021.06.004_bib0097","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1186\/1744-8069-5-45","article-title":"Descending serotonergic facilitation and the antinociceptive effects of pregabalin in a rat model of osteoarthritic pain","volume":"5","author":"Rahman","year":"2009","journal-title":"Mol Pain"},{"key":"10.1016\/j.seizure.2021.06.004_bib0098","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jocn.2018.09.019","article-title":"Gabapentin or pregabalin induced myoclonus: a case series and literature review","volume":"61","author":"Desai","year":"2019","journal-title":"J Clin Neurosci"},{"issue":"2","key":"10.1016\/j.seizure.2021.06.004_bib0099","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1212\/WNL.45.2.219","article-title":"Serotonin syndrome","volume":"45","author":"Bodner","year":"1995","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.seizure.2021.06.004_bib0100","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00127893-199909000-00005","article-title":"Serotonin syndrome: a frequently missed diagnosis? Let the neurologist beware","volume":"5","author":"Birbeck","year":"1999","journal-title":"The Neurologist."},{"issue":"1","key":"10.1016\/j.seizure.2021.06.004_bib0101","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF02245789","article-title":"Effects of carbamazepine on 5-hydroxytryptamine function in rodents","volume":"100","author":"Elphick","year":"1990","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.seizure.2021.06.004_bib0102","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0920-1211(98)00025-4","article-title":"Effects of carbamazepine on hippocampal serotonergic system","volume":"31","author":"Okada","year":"1998","journal-title":"Epilepsy Res"},{"issue":"10","key":"10.1016\/j.seizure.2021.06.004_bib0103","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/j.1528-1157.1998.tb01290.x","article-title":"Carbamazepine-induced release of serotonin from rat hippocampus in vitro","volume":"39","author":"Dailey","year":"1998","journal-title":"Epilepsia"},{"issue":"2\u20133","key":"10.1016\/j.seizure.2021.06.004_bib0104","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.eplepsyres.2005.02.002","article-title":"Lamotrigine, carbamazepine and phenytoin differentially alter extracellular levels of 5-hydroxytryptamine, dopamine and amino acids","volume":"63","author":"Ahmad","year":"2005","journal-title":"Epilepsy Res"},{"issue":"2","key":"10.1016\/j.seizure.2021.06.004_bib0105","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1476-5381.1957.tb00125.x","article-title":"Anticonvulsant compounds and 5-hydroxytryptamine in rat brain","volume":"12","author":"Bonnycastle","year":"1957","journal-title":"Br J Pharmacol Chemother"},{"issue":"7","key":"10.1016\/j.seizure.2021.06.004_bib0106","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/BF00969688","article-title":"Effect of chronic administration of phenytoin on regional monoamine levels in rat brain","volume":"20","author":"Meshkibaf","year":"1995","journal-title":"Neurochem Res"},{"issue":"2","key":"10.1016\/j.seizure.2021.06.004_bib0107","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0920-1211(92)90066-3","article-title":"Effects of zonisamide on extracellular levels of monoamine and its metabolite, and on Ca2+ dependent dopamine release","volume":"13","author":"Okada","year":"1992","journal-title":"Epilepsy Res"},{"issue":"2","key":"10.1016\/j.seizure.2021.06.004_bib0108","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.neulet.2012.03.056","article-title":"Levetiracetam inhibits neurotransmitter release associated with CICR","volume":"518","author":"Fukuyama","year":"2012","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.seizure.2021.06.004_bib0109","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.genhosppsych.2020.05.005","article-title":"Attitude and Practice (KAP) Study on serotonin syndrome among psychiatrists","volume":"67","author":"Prakash","year":"2020","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.seizure.2021.06.004_bib0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2019.113145","article-title":"Serotonin and sudden unexpected death in epilepsy","volume":"325","author":"Petrucci","year":"2020","journal-title":"Exp Neurol"},{"issue":"9156","key":"10.1016\/j.seizure.2021.06.004_bib0111","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S0140-6736(98)05114-9","article-title":"Risk factors for sudden unexpected death in epilepsy: a case-control study","volume":"353","author":"Nilsson","year":"1999","journal-title":"Lancet"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131121001874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131121001874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:59:44Z","timestamp":1761011984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131121001874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":111,"alternative-id":["S1059131121001874"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2021.06.004","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiepileptic drugs and serotonin syndrome- A systematic review of case series and case reports","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2021.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}